Chithra Sangli

Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer

Maureen Cronin, Chithra Sangli, Mei‐Lan Liu et al. · Clinical Chemistry · 2007 · 345 citations · Full text

Medicine, Molecular Biology, Oncology +17

Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After MitraClip Therapy

Paul Grayburn, Elyse Foster, Chithra Sangli et al. · Circulation · 2013 · 172 citations · Full text

Medicine, Cardiology, Surgery +13

Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy

Charu Aggarwal, Rotem Ben-Shachar, Yinjie Gao et al. · JAMA Network Open · 2023 · 122 citations · Full text

Pharmacy, Immunology, Oncology +17

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay

Kim M. Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar et al. · BMC Cancer · 2010 · 94 citations · Full text

Medicine, Cancer Biology, Oncology +17

The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison

Eric J. Velazquez, Zainab Samad, Hussein R. Al‐Khalidi et al. · American Heart Journal · 2015 · 77 citations

Medicine, Cardiology, Surgery +14